Price to Earnings (P/E)
since 2005
Calculation
Thermo Fisher Scientific Inc., P/E, long-term trends, calculation
| P/E | = | Share price1, 2, 3 | ÷ | Earnings per share1 (EPS) | EPS1 | = | Net income attributable to Thermo Fisher Scientific Inc.1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2025 | 32.03 | = | 537.83 | ÷ | 16.79 | 16.79 | = | 6,335 | ÷ | 377,261,182 | |
| Feb 22, 2024 | 35.65 | = | 560.49 | ÷ | 15.72 | 15.72 | = | 5,995 | ÷ | 381,312,268 | |
| Feb 23, 2023 | 30.55 | = | 550.95 | ÷ | 18.03 | 18.03 | = | 6,950 | ÷ | 385,430,077 | |
| Feb 24, 2022 | 27.35 | = | 540.17 | ÷ | 19.75 | 19.75 | = | 7,725 | ÷ | 391,191,770 | |
| Feb 25, 2021 | 27.89 | = | 451.47 | ÷ | 16.19 | 16.19 | = | 6,375 | ÷ | 393,793,362 | |
| Feb 26, 2020 | 33.36 | = | 309.16 | ÷ | 9.27 | 9.27 | = | 3,696 | ÷ | 398,828,389 | |
| Feb 27, 2019 | 35.19 | = | 259.14 | ÷ | 7.36 | 7.36 | = | 2,938 | ÷ | 399,003,681 | |
| Feb 28, 2018 | 37.66 | = | 208.58 | ÷ | 5.54 | 5.54 | = | 2,225 | ÷ | 401,784,066 | |
| Feb 28, 2017 | 30.45 | = | 157.68 | ÷ | 5.18 | 5.18 | = | 2,022 | ÷ | 390,391,061 | |
| Feb 25, 2016 | 26.19 | = | 130.57 | ÷ | 4.99 | 4.99 | = | 1,975 | ÷ | 396,261,928 | |
| Feb 26, 2015 | 27.26 | = | 130.14 | ÷ | 4.77 | 4.77 | = | 1,894 | ÷ | 396,782,757 | |
| Feb 27, 2014 | 38.43 | = | 124.91 | ÷ | 3.25 | 3.25 | = | 1,273 | ÷ | 391,792,194 | |
| Feb 27, 2013 | 22.54 | = | 74.25 | ÷ | 3.29 | 3.29 | = | 1,178 | ÷ | 357,625,034 | |
| Feb 29, 2012 | 15.58 | = | 56.62 | ÷ | 3.64 | 3.64 | = | 1,330 | ÷ | 365,853,610 | |
| Feb 24, 2011 | 20.87 | = | 55.33 | ÷ | 2.65 | 2.65 | = | 1,036 | ÷ | 390,607,016 | |
| Feb 26, 2010 | 23.49 | = | 48.77 | ÷ | 2.08 | 2.08 | = | 850 | ÷ | 409,461,414 | |
| Feb 27, 2009 | 15.25 | = | 36.26 | ÷ | 2.38 | 2.38 | = | 994 | ÷ | 418,164,910 | |
| Feb 29, 2008 | 30.76 | = | 55.93 | ÷ | 1.82 | 1.82 | = | 761 | ÷ | 418,600,105 | |
| Mar 1, 2007 | 113.28 | = | 45.56 | ÷ | 0.40 | 0.40 | = | 169 | ÷ | 420,030,996 | |
| Mar 2, 2006 | 25.36 | = | 34.78 | ÷ | 1.37 | 1.37 | = | 223 | ÷ | 162,738,621 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Thermo Fisher Scientific Inc. Annual Report.
- Share Price
- The share price shows an overall upward trend across the periods analyzed, starting at $34.78 in early 2006 and peaking around $560.49 in early 2024 before slightly declining to $537.83 in early 2025. There are some notable fluctuations, including a substantial dip to $36.26 in early 2009, likely influenced by broader market conditions at the time. After this trough, the price steadily increased, with significant acceleration from 2013 onward, featuring particularly rapid price appreciation between 2018 and 2021. The increase reflected strong investor confidence or positive company performance.
- Earnings Per Share (EPS)
- EPS demonstrated variability in the earlier years, falling from $1.37 in early 2006 to a low of $0.40 in early 2007. From 2007 onward, EPS generally increased, with some minor fluctuations but a clear upward trajectory predominantly post-2010. Noteworthy rises occur after 2015, culminating in a peak of $19.75 in early 2022. A slight decline is observed during 2023, with a partial recovery in 2024 and 2025 to $16.79. This pattern suggests consistent profitability growth over the long term, reflecting improved operational performance or increased earnings capacity.
- Price-to-Earnings (P/E) Ratio
- The P/E ratio presents a more variable pattern over the years. Early observations show a very high ratio of 113.28 in early 2007, indicating the market price was high relative to earnings at that time, perhaps due to investor speculation or anticipation of growth. The ratio then decreases to more moderate levels, fluctuating mostly between approximately 15 and 38. Notably, the P/E ratio peaked again around 38.43 in early 2014, before gradually declining to the high 20s and low 30s range in recent years. The variability suggests shifts in market valuation, possibly reflecting changing investor sentiment or expectations about future growth.
- Summary of Trends
- Over the nearly two-decade period, the data indicate robust growth in both share price and earnings per share, despite some intermittent volatility. The share price and EPS growth generally align, with periods of share price acceleration corresponding with rising EPS. Meanwhile, the P/E ratio exhibits variability, reflecting fluctuations in market valuation sentiment independent of fundamental earnings growth. The recent leveling or slight decline in the P/E ratio, coupled with modest EPS declines, may indicate market adjustments or changing expectations about future performance.
Comparison to Competitors
Thermo Fisher Scientific Inc., P/E, long-term trends, comparison to competitors
| Thermo Fisher Scientific Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2025 | 32.03 | 79.59 | 38.24 | — | 38.12 | 77.63 | 296.57 | 26.92 | 13.49 | 18.42 | 17.76 | — |
| Feb 22, 2024 | 35.65 | 63.84 | 23.14 | 12.27 | 39.09 | 135.24 | 16.17 | 10.73 | 893.99 | 73.42 | 25.99 | 30.42 |
| Feb 23, 2023 | 30.55 | 22.62 | 19.56 | 23.97 | 25.65 | 50.08 | 22.68 | 22.97 | 19.21 | 7.58 | 19.68 | 23.02 |
| Feb 24, 2022 | 27.35 | 22.07 | 21.05 | 20.92 | 29.94 | 40.66 | 12.36 | 20.93 | 14.78 | 11.76 | 8.37 | 26.55 |
| Feb 25, 2021 | 27.89 | 40.17 | 18.82 | — | 44.49 | 31.95 | 641.48 | 28.92 | 26.72 | 19.62 | 15.09 | 20.18 |
| Feb 26, 2020 | 33.36 | 17.82 | 17.07 | 41.99 | 38.34 | 16.19 | 16.45 | 25.99 | 20.60 | 11.63 | 19.86 | 52.90 |
| Feb 27, 2019 | 35.19 | 20.60 | 14.01 | 16.81 | 29.77 | 39.13 | 15.26 | 23.74 | 33.46 | 21.58 | 18.17 | 22.59 |
| Feb 28, 2018 | 37.66 | 35.47 | 64.06 | 103.55 | 27.25 | — | 22.75 | 268.10 | 61.63 | 9.99 | 28.99 | 155.08 |
| Feb 28, 2017 | 30.45 | 16.54 | 16.03 | 20.56 | 23.02 | 32.39 | 6.83 | 20.08 | 46.14 | 28.10 | 42.64 | — |
| Feb 25, 2016 | 26.19 | 17.01 | 15.95 | 64.22 | 17.85 | 33.35 | 6.75 | 18.80 | 31.64 | 26.37 | 60.50 | — |
| Feb 26, 2015 | 27.26 | 55.08 | 22.96 | 49.80 | 23.69 | 33.06 | 12.85 | 17.15 | 13.94 | 23.03 | 118.44 | — |
| Feb 27, 2014 | 38.43 | 19.64 | 18.69 | 35.01 | 19.74 | 13.88 | 42.00 | 18.72 | 37.83 | 9.32 | 77.00 | — |
| Feb 27, 2013 | 22.54 | 11.51 | 15.68 | 30.56 | 17.73 | 14.99 | 25.20 | 19.64 | 20.94 | 13.51 | 21.42 | — |
| Feb 29, 2012 | 15.58 | — | 14.61 | 15.07 | 16.92 | 10.42 | 12.20 | 18.48 | 18.63 | 15.99 | — | 267.42 |
| Feb 24, 2011 | 20.87 | — | 10.53 | 13.99 | 18.29 | 7.86 | 10.68 | 12.23 | 116.63 | 18.63 | — | — |
| Feb 26, 2010 | 23.49 | — | 12.10 | 4.03 | 20.93 | 9.18 | 16.29 | 14.22 | 9.00 | 16.41 | — | — |
| Feb 27, 2009 | 15.25 | — | 12.06 | 7.68 | 12.56 | — | 20.29 | 11.67 | 6.53 | 10.25 | — | — |
| Feb 29, 2008 | 30.76 | — | 15.64 | 20.60 | 17.35 | 19.26 | 25.19 | 17.07 | 29.88 | 18.51 | — | — |
| Mar 1, 2007 | 113.28 | — | 25.43 | 34.64 | 19.65 | 22.40 | — | 17.02 | 21.57 | 9.18 | — | — |
| Mar 2, 2006 | 25.36 | — | 23.70 | 14.96 | 21.38 | 31.90 | 34.15 | 16.95 | 16.62 | 23.92 | — | — |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Thermo Fisher Scientific Inc., P/E, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Thermo Fisher Scientific Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Feb 20, 2025 | 32.03 | 45.15 |
| Feb 22, 2024 | 35.65 | 32.80 |
| Feb 23, 2023 | 30.55 | 20.23 |
| Feb 24, 2022 | 27.35 | 19.27 |
| Feb 25, 2021 | 27.89 | 34.89 |
| Feb 26, 2020 | 33.36 | 21.03 |
| Feb 27, 2019 | 35.19 | 22.89 |
| Feb 28, 2018 | 37.66 | 35.21 |
| Feb 28, 2017 | 30.45 | 20.62 |
| Feb 25, 2016 | 26.19 | 19.37 |
| Feb 26, 2015 | 27.26 | 21.40 |
| Feb 27, 2014 | 38.43 | 19.54 |
| Feb 27, 2013 | 22.54 | 17.56 |
| Feb 29, 2012 | 15.58 | 16.42 |
| Feb 24, 2011 | 20.87 | 16.11 |
| Feb 26, 2010 | 23.49 | 11.66 |
| Feb 27, 2009 | 15.25 | 12.21 |
| Feb 29, 2008 | 30.76 | 20.04 |
| Mar 1, 2007 | 113.28 | 17.46 |
| Mar 2, 2006 | 25.36 | 20.94 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Thermo Fisher Scientific Inc., P/E, long-term trends, comparison to industry (health care)
| Thermo Fisher Scientific Inc. | Health Care | |
|---|---|---|
| Feb 20, 2025 | 32.03 | 37.14 |
| Feb 22, 2024 | 35.65 | 29.43 |
| Feb 23, 2023 | 30.55 | 342,408.13 |
| Feb 24, 2022 | 27.35 | 21.35 |
| Feb 25, 2021 | 27.89 | 30.75 |
| Feb 26, 2020 | 33.36 | 21.64 |
| Feb 27, 2019 | 35.19 | 25.29 |
| Feb 28, 2018 | 37.66 | 30.93 |
| Feb 28, 2017 | 30.45 | 21.47 |
| Feb 25, 2016 | 26.19 | 19.50 |
| Feb 26, 2015 | 27.26 | 21.56 |
| Feb 27, 2014 | 38.43 | 18.62 |
| Feb 27, 2013 | 22.54 | 15.80 |
| Feb 29, 2012 | 15.58 | 15.84 |
| Feb 24, 2011 | 20.87 | 15.00 |
| Feb 26, 2010 | 23.49 | 11.75 |
| Feb 27, 2009 | 15.25 | 12.99 |
| Feb 29, 2008 | 30.76 | 19.44 |
| Mar 1, 2007 | 113.28 | 18.63 |
| Mar 2, 2006 | 25.36 | 21.68 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).